India to take part in WHO's 'solidarity trial', says ICMR
India will participate in the World Health Organisation's (WHO) multi-country 'solidarity trial' for developing potential treatments and drugs for COVID-19, the Indian Council of Medical Research (ICMR) said on Friday.
- Country:
- India
India will participate in the World Health Organisation's (WHO) multi-country 'solidarity trial' for developing potential treatments and drugs for COVID-19, the Indian Council of Medical Research (ICMR) said on Friday. "ICMR will collaborate with WHO for public health emergency 'Solidarity Trial' -- an international randomised trial of additional treatments for COVID-19 in hospitalised patients," ICMR said.
It will be coordinated in India by Dr Sheela Godbole, Scientist, ICMR-National AIDS Research Institute in Pune. Earlier on March 27, Dr R Ganga Ketkar of ICMR said that India was likely to participate in the WHO's 'solidarity trial' for a potential treatment for COVID-19.
Addressing a press conference, he had said, "We are likely to start our participation soon in the solidarity trial that the WHO is starting." Coronavirus continued to rise on Friday with India's tally climbing to 2,547, including 162 cured or discharged and 62 deaths, according to the Union Ministry of Health and Family Welfare. (ANI)
ALSO READ
-
Kazakhstan Connects Over 200 Health Workers With Global Clinical Research Experts
-
Higher Tobacco Taxes Cut Smoking and Show How Health Levies Can Change Daily Lives
-
Better Heat Planning Can Protect Crowds and Ease Pressure on Hospitals, WHO Says
-
Japanese Lawmakers Visit India to See Worker Protection and Skills Projects in Action
-
Indian Unions Push for Fair Recruitment and Rights for Care Workers in Germany
Google News